Literature DB >> 7798295

Sublethal damage repair after fractionated irradiation in endometrial cancer cell lines tested with the 96-well plate clonogenic assay.

V Rantanen1, S Grénman, J Kulmala, K Alanen, T Lakkala, R Grénman.   

Abstract

Two long-established and seven newly established endometrial adenocarcinoma cell lines were tested for their capacity to repair sublethal damage after fractionated irradiation. Cell survival was determined with the 96-well plate clonogenic assay based on limiting dilutions. Total radiation doses of 0.75 Gy, 1.25 Gy, 2.50 Gy, 5.00 Gy and 7.50 Gy were used either as a single dose or divided into two or three equal fractions with a 24 h interval. Survival data were fitted to the linear quadratic model, and the area under the survival curve (AUC), equivalent to the mean inactivation dose, was obtained with numerical integration. The amount of sublethal damage repair (SLDR) was expressed as an area-under-the-curve (AUC) ratio comparing survivals from fractionated-dose with those from single-dose experiments. SLDR capacity of the cell lines expressed as an AUC ratio varied between 1.00 and 1.59, and the mean was 1.17. Two highly radiosensitive cell lines were found to be SLDR-deficient, but most of the cell lines studied had some SLDR capacity. We have earlier shown that endometrial cancer cell lines as a group are more radiosensitive than squamous-cell carcinoma (SCC) lines. Data obtained in this study suggest that the capacity for SLDR in these cell lines is rather limited compared with the majority of SCC lines tested. This finding underlines further the high radioresponsiveness of endometrial cancer.

Entities:  

Mesh:

Year:  1994        PMID: 7798295     DOI: 10.1007/bf01194268

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  26 in total

1.  Prediction of cervical carcinoma response to radiotherapy.

Authors:  C M West; S E Davidson; J H Hendry; R D Hunter
Journal:  Lancet       Date:  1991-09-28       Impact factor: 79.321

2.  Radiosensitivity of head and neck cancer cells in vitro. A 96-well plate clonogenic cell assay for squamous cell carcinoma.

Authors:  R Grenman; D Burk; E Virolainen; J G Wagner; A S Lichter; T E Carey
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1988-04

3.  UM-EC-1, a new hypodiploid human cell line derived from a poorly differentiated endometrial cancer.

Authors:  S E Grenman; D L Van Dyke; M J Worsham; F del Rosario; J A Roberts; K D McClatchey; D R Schwartz; V R Babu; T E Carey
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

4.  Dosimetry of irradiation models. The 96-well clonogenic assay for testing radiosensitivity of cell lines.

Authors:  J Kulmala; V Rantanen; K Pekkola-Heino; J Tuominen; R Grénman
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

5.  Radiation sensitivity of endometrial carcinoma in vitro.

Authors:  V Rantanen; S Grénman; J Kulmala; T Salmi; R Grénman
Journal:  Gynecol Oncol       Date:  1992-03       Impact factor: 5.482

6.  KLE: a cell line with defective estrogen receptor derived from undifferentiated endometrial cancer.

Authors:  G S Richardson; G R Dickersin; L Atkins; D T MacLaughlin; S Raam; L P Merk; F M Bradley
Journal:  Gynecol Oncol       Date:  1984-02       Impact factor: 5.482

7.  Radiation response characteristics of human cells in vitro.

Authors:  E J Hall; M Marchese; T K Hei; M Zaider
Journal:  Radiat Res       Date:  1988-06       Impact factor: 2.841

8.  Establishment and characterization of UM-EC-2, a tamoxifen-sensitive, estrogen receptor-negative human endometrial carcinoma cell line.

Authors:  S E Grenman; M J Worsham; D L Van Dyke; B England; K D McClatchey; V R Babu; J A Roberts; J Mäenpää; T E Carey
Journal:  Gynecol Oncol       Date:  1990-05       Impact factor: 5.482

9.  Characterization and radiosensitivity of UT-EC-2A and UT-EC-2B, two new highly radiosensitive endometrial cancer cell lines derived from a primary and metastatic tumor of the same patient.

Authors:  V Rantanen; S Grénman; J Kulmala; M Jaakkola; T Lakkala; A Sajantila; P Klemi; R Grénman
Journal:  Gynecol Oncol       Date:  1995-01       Impact factor: 5.482

10.  Effects of radiation fractionation on four squamous cell carcinoma lines with dissimilar inherent radiation sensitivity.

Authors:  K Pekkola-Heino; J Kulmala; P Klemi; T Lakkala; K Aitasalo; H Joensuu; R Grenman
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

View more
  3 in total

1.  Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.

Authors:  T A Järvinen; M Tanner; V Rantanen; M Bärlund; A Borg; S Grénman; J Isola
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.

Authors:  V Rantanen; S Grénman; J Kulmala; R Grénman
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

3.  Breast cancer stem cell-like cells are more sensitive to ionizing radiation than non-stem cells: role of ATM.

Authors:  Seog-Young Kim; Juong G Rhee; Xinxin Song; Edward V Prochownik; Douglas R Spitz; Yong J Lee
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.